- VIVUS Announces Date of 2016 First Quarter Business Update and Financial Results Teleconference
- VIVUS Reports Fourth Quarter and Year-End 2015 Financial Results
- VIVUS Announces Date of Fourth Quarter 2015 Update and Financial Results Teleconference
- VIVUS, Inc. Announces Intent to Reacquire U.S. and Canadian Rights for Stendra(R) (Avanafil)
- A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
A Growing Pipeline
VIVUS is developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health.